Trial record 1 of 2 for:
AMT-130
Safety and Efficacy of AMT-130 in European Adults With Early Manifest Huntington's Disease
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05243017 |
Recruitment Status :
Recruiting
First Posted : February 16, 2022
Last Update Posted : May 6, 2024
|
Sponsor:
UniQure Biopharma B.V.
Information provided by (Responsible Party):
UniQure Biopharma B.V.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | March 2029 |
Estimated Study Completion Date : | October 7, 2029 |